Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma

This study has been terminated.
(Withdrawn due to an excess of toxic deaths)
Sponsor:
Collaborator:
European Inter-Group Co-operation on Childhood Non-Hodgkin Lymphoma
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00275106
First received: January 10, 2006
Last updated: July 9, 2013
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)